Boston, Massachusetts–(Newsfile Corp. – June 10, 2025) – Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today…Read More

You might also be interested in reading Kopin GAAP EPS of -$0.02 misses by $0.01, revenue of $10.54M beats by $0.05M.